title: [Effect of anxin granules combined with tirofiba on patients with acute myocardial infarction after elective percutaneous coronary intervention].
abstract: To investigate the influence of Anxin granules combined with tirofiban on acute myocardial infarction (AMI) Patients after elective percutaneous coronary intervention (PCI). One hundred and twenty AMI patients were randomly divided into treatment group and control group. The patients in the two groups were all given Tirofiban 30mins before PCI . The treatment group was added Anxin granules 30 mins before and after PCI. Tissue factor (TF) and von willebrand factor (vWF) were tested at 6 hours after operation. Syndromatology alteration of traditional Chinese medicine (TCM) and bleeding complications were observed at 4 weeks after operation. Both TF and vWF at 6 hours after operation of the treatment group was lower than the control group significantly (P < 0.01), while the condition of myocardial ischemia at 90 mins after operation of the treatment group was better than control group with significance. The syndromatology alteration of TCM especially spontaneous perspiration and hypodynamia of the treatment group were improved significantly compared to control group 4 weeks after operation. All patients in both groups had no bleeding complications and thrombopenia. The study suggests that Anxin granules combined with tirofiba can improve the clinical efficacy and the endothelial function of AMI patients after PCI with no increase in bleeding events.
authors.forename: Jian-Qi
authors.initials: JQ
authors.lastname: Lu
authors.forename: Gui-Xin
authors.initials: GX
authors.lastname: He
authors.forename: Chao-Xin
authors.initials: CX
authors.lastname: Pan
authors.forename: Zhi-Hao
authors.initials: ZH
authors.lastname: Wen
authors.forename: Yi-Kun
authors.initials: YK
authors.lastname: Zhang
authors.forename: Xian-Ming
authors.initials: XM
authors.lastname: Fang
authors.forename: Tai-Hua
authors.initials: TH
authors.lastname: Guo
authors.forename: Ai-Ping
authors.initials: AP
authors.lastname: Pan
authors.forename: Hai-Shan
authors.initials: HS
authors.lastname: Wu
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000378:metabolism / Q000601:surgery*; D019106:Postoperative Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control; D013925:Thromboplastin / Q000378:metabolism; D014841:von Willebrand Factor / Q000378:metabolism
chemical_list: D004365:Drugs, Chinese Herbal; D014841:von Willebrand Factor; D013925:Thromboplastin